Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-24T14:04:47.861Z Has data issue: false hasContentIssue false
  • English
  • Français

Everolimus treatment of a newborn with rhabdomyoma causing severe arrhythmia

Published online by Cambridge University Press:  20 November 2014

Funda Öztunç ,
Sezen U. Atik  and
Aslı O. Güneş
Funda Öztunç
Affiliation:
Department of Pediatric Cardiology, Cerrahpaşa Medical Faculty, Istanbul University, Istanbul, Turkey
Sezen U. Atik*
Affiliation:
Department of Pediatric Cardiology, Cerrahpaşa Medical Faculty, Istanbul University, Istanbul, Turkey
Aslı O. Güneş
Affiliation:
Department of Pediatric Cardiology, Cerrahpaşa Medical Faculty, Istanbul University, Istanbul, Turkey
*
Correspondence to: S. U. Atik, Department of Pediatric Cardiology, Cerrahpaşa Medical Faculty, Istanbul University, 34303 İstanbul, Turkey. Tel: +90 506 367 21 88; Fax: +90 212 632 00 50; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Rhabdomyoma is the most common cardiac tumour in children often associated with tuberous sclerosis. Arrhythmia caused by cardiac rhabdomyomas may be the initial sign of tuberous sclerosis. Rhabdomyomas unresponsive to other treatments could be successfully managed with everolimus, which has demonstrated benefit in tuberous sclerosis. We report a case of rhabdomyoma causing severe arrhythmia in a newborn managed successfully with everolimus.

Keywords

Rhabdomyomaarrhythmiaeverolimus
Type
Brief Reports
Information
Cardiology in the Young , Volume 25 , Issue 7 , October 2015 , pp. 1411 - 1414
Copyright
© Cambridge University Press 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Uzun, O, Wilson, DG, Vujanic, GM, Parsons, JM, de Giovanni, J. Cardiac tumors in children. Orphanet J Rare Dis 2007; 2: 11–25.CrossRefGoogle Scholar
2. Butany, J, Nair, V, Nassemuddin, A, Nair, GM, Catton, C, Yau, T. Cardiactumours: diagnosis and management. Lanset Oncol 2005; 6: 219–228.CrossRefGoogle ScholarPubMed
3. Watson, GH. Cardiac rhabdomyoma in tuberous sclerosis. Ann N Y Acad Sci 1991; 61: 50–57.CrossRefGoogle Scholar
4. Bosi, G, Linthermans, JP, Pellegrino, PA, Svaluto-Moreolo, G, Vliers, A. The natural history of cardiac rhabdomyoma with and without tuberous sclerosis. Acta Paediatr 1996; 85: 928–931.CrossRefGoogle ScholarPubMed
5. Penha, JG, Zorzanelli, L, Barbosa-Lopes, AA, et al. Heart neoplasm in children: retrospective analysis. Arq Bras Cardiol 2013; 100: 120–126.CrossRefGoogle ScholarPubMed
6. Demir, HA, Ekici, F, Yazal Erdem, A, Emir, S, Tunç, B. Everolimus: a challenging drug in the treatment of multifocal inoperable cardiac rhabdomyoma. Pediatrics 2012; 130: 243–247.CrossRefGoogle ScholarPubMed
7. Tiberio, D, Franz, DN, Phillips, JR. Regression of a cardiac rhabdomyoma in a patient receiving everolimus. Regression of a cardiac rhabdomyoma in a patient receiving everolimus. Pediatrics 2011; 127: 1335–1337.CrossRefGoogle Scholar
8. Marx, GR, Moran, AM. Cardiac tumors. In: Allen HD, Driscoll DJ, Shaddy RE, Feltes TF (eds). Moss and Adams’ Heart Disease in Infants, Children and Adolescents: Including the Fetus and Young Adults, 7th edn. Lippincott Williams & Wilkins, Philadelphia, 2008: 1479–1484.Google Scholar
9. Mas, C, Penny, DJ, Menahem, S. Pre-excitation syndrome secondary to cardiac rhabdomyomas in tuberous sclerosis. J Paediatr Child Health 2000; 36: 84–86.CrossRefGoogle ScholarPubMed
10. Miyake, CY, Del Nido, PJ, Alexander, ME, et al. Cardiac tumors and associated arrhythmias in pediatric patients, with observations on surgical therapy for ventricular tachycardia. J Am Coll Cardiol 2011; 58: 1903–1909.CrossRefGoogle ScholarPubMed
11. Saada, J, Hadj Rabia, S, Fermont, I, et al. Prenatal diagnosis of cardiac rhabdomyomas: incidence of associated cerebral lesions of tuberous sclerosis complex. Ultrasound Obstet Gynecol 2009; 34: 155–159.CrossRefGoogle ScholarPubMed
12. Moavero, R, Coniglio, A, Garaci, F, Curatolo, P. Is mTOR inhibition a systemic treatment for tuberous sclerosis? Ital J Pediatr 2013; 39: 57.CrossRefGoogle ScholarPubMed
13. Grünwald, V, Weikert, S, Pavel, ME, et al. Practical management of everolimus-related toxicities in patients with advanced solid tumors. Onkologie 2013; 36: 295–302.Google ScholarPubMed